Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness: An Official ATS/AAHPM/HPNA/SWHPN Policy Statement

Donald R Sullivan, Anand S Iyer, Susan Enguidanos, Christopher E Cox, Morag Farquhar, Daisy J A Janssen, Kathleen O Lindell, Richard A Mularski, Natasha Smallwood, Alison E Turnbull, Anne M Wilkinson, Katherine R Courtright, Matthew Maddocks, Mary Lynn McPherson, J Daryl Thornton, Margaret L Campbell, Tracy K Fasolino, Patricia M Fogelman, Larry Gershon, Thayer Gershon, Christiane Hartog, Judy Luther, Diane E Meier, Judith E Nelson, Elliot Rabinowitz, Cynda H Rushton, Danetta H Sloan, Erin K Kross, Lynn F Reinke, Donald R Sullivan, Anand S Iyer, Susan Enguidanos, Christopher E Cox, Morag Farquhar, Daisy J A Janssen, Kathleen O Lindell, Richard A Mularski, Natasha Smallwood, Alison E Turnbull, Anne M Wilkinson, Katherine R Courtright, Matthew Maddocks, Mary Lynn McPherson, J Daryl Thornton, Margaret L Campbell, Tracy K Fasolino, Patricia M Fogelman, Larry Gershon, Thayer Gershon, Christiane Hartog, Judy Luther, Diane E Meier, Judith E Nelson, Elliot Rabinowitz, Cynda H Rushton, Danetta H Sloan, Erin K Kross, Lynn F Reinke

Abstract

Background: Patients with serious respiratory illness and their caregivers suffer considerable burdens, and palliative care is a fundamental right for anyone who needs it. However, the overwhelming majority of patients do not receive timely palliative care before the end of life, despite robust evidence for improved outcomes. Goals: This policy statement by the American Thoracic Society (ATS) and partnering societies advocates for improved integration of high-quality palliative care early in the care continuum for patients with serious respiratory illness and their caregivers and provides clinicians and policymakers with a framework to accomplish this. Methods: An international and interprofessional expert committee, including patients and caregivers, achieved consensus across a diverse working group representing pulmonary-critical care, palliative care, bioethics, health law and policy, geriatrics, nursing, physiotherapy, social work, pharmacy, patient advocacy, psychology, and sociology. Results: The committee developed fundamental values, principles, and policy recommendations for integrating palliative care in serious respiratory illness care across seven domains: 1) delivery models, 2) comprehensive symptom assessment and management, 3) advance care planning and goals of care discussions, 4) caregiver support, 5) health disparities, 6) mass casualty events and emergency preparedness, and 7) research priorities. The recommendations encourage timely integration of palliative care, promote innovative primary and secondary or specialist palliative care delivery models, and advocate for research and policy initiatives to improve the availability and quality of palliative care for patients and their caregivers. Conclusions: This multisociety policy statement establishes a framework for early palliative care in serious respiratory illness and provides guidance for pulmonary-critical care clinicians and policymakers for its proactive integration.

Keywords: advance care planning; caregivers; healthcare disparities; lung diseases; quality of life.

Figures

Figure 1.
Figure 1.
Levels of palliative care. This figure illustrates the who, where, what, and when of palliative care across three levels of increasing proficiency and expertise (primary, secondary or specialist, and tertiary palliative care). ACP = advanced care planning; GOC = goals of care.
Figure 2.
Figure 2.
Multiphase iterative development of the policy statement. This figure illustrates the four phases of iterative development of the policy statement over multiple years through conceptualization (phase 1), preparation (phase 2), presentation, facilitation, and exploration (phase 3), and integration and compilation (phase 4).
Figure 3.
Figure 3.
Primary and secondary palliative care integration in serious respiratory illness. This figure has three panels. In the top panel, the x-axis denotes patient wellbeing and function, and the y-axis denotes time. The top panel illustrates the hypothetical integration of palliative care across illness trajectories of lung cancer (red dashed line), pulmonary hypertension (blue line), and chronic obstructive pulmonary disease/interstitial lung disease (COPD/ILD; gold line), each punctuated by declines in wellbeing at hospitalizations (stars) and potential lung transplant referral (diamonds). The integration of primary palliative care (orange circles) starts early (seeFigure 4 for triggers), and the integration of secondary palliative care (blue circles) is added later, but well before the end of life. In the middle panel, the x-axis denotes palliative care intensity, and the y-axis denotes time. Primary palliative care increases in intensity after initiation (expanding orange triangle) as serious respiratory illness worsens, and secondary palliative care starts later and also increases in intensity but layers on top of secondary palliative care (expanding blue triangle). Through ongoing comanagement, a period of collaborative primary and secondary palliative care (overlapping triangles) should occur as illness severity worsens through the end of life. The bottom panel illustrates how palliative care may evolve across a continuum of serious respiratory illness. When illness is less severe, palliative care occurs concurrent with illness-directed therapies and then shifts focus from cure to end-of-life care (e.g., hospice and bereavement support) near and after death. This figure is adapted by permission from Iyer, AF. The Role of Palliative Care in COPD. Chest 2022;161: 1250–1262.
Figure 4.
Figure 4.
Triggers for initiating primary and secondary palliative care in serious respiratory illness: the levers model. Hypothetical triggers for primary and secondary palliative care occur across multiple domains: lung function, symptoms, care needs, exacerbations, advanced therapies, and caregivers. The x-axis denotes worsening illness severity, whereas the y-axis denotes multiple domains, each with a circle functioning as a lever that can move up or down, crossing a threshold for primary or secondary palliative care, illustrated by the dashed lines. Any one or multiple domains can cross a trigger threshold for consideration for primary or secondary palliative care initiation. For example, a person can trigger consideration for primary palliative care when their FEV1 drops below 50% predicted (lung function domain). Also, a person can trigger consideration for secondary palliative care when their breathlessness becomes severe on the Modified Medical Research Council (mMRC) (symptoms domain). 6MWD = 6-minute-walk distance; CSNAT = carer support needs assessment tool. This figure is adapted by permission from Iyer, AF. The Role of Palliative Care in COPD. Chest 2022;161: 1250–1262.
Figure 5.
Figure 5.
Continuum of advance care planning integration in serious respiratory illness. The continuum of ACP in serious respiratory illness is a longitudinal process of communication that begins soon after illness diagnosis (stage 1: first arrow) and increases in intensity on the basis of patient illness trajectory (stages 2–4). This process should be free of coercion, and clinicians should be alert to signs of patient distress or discomfort. Patient-designated surrogates or healthcare proxies should be included across all stages with patient permission. ACP = advance care planning.

References

    1. Lanken PN, Terry PB, Delisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, et al. ATS End-of-Life Care Task Force An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med . 2008;177:912–927.
    1. Growth of palliative care in U.S 2021.
    1. Kamal AH, Bull JH, Swetz KM, Wolf SP, Shanafelt TD, Myers ER. Future of the palliative care workforce: preview to an impending crisis. Am J Med . 2017;130:113–114.
    1. Morrison RS, Meier DE.America’s care of serious illness: a state-by-state report card on access to palliative care in our nation’s hospitals. New York: Center to Advance Palliative Care; 2019.
    1. Clark D, Baur N, Clelland D, Garralda E, López-Fidalgo J, Connor S, et al. Mapping levels of palliative care development in 198 countries: the situation in 2017. J Pain Symptom Manage . 2020;59:794–807.e4.
    1. Kelley AS, Bollens-Lund E. Identifying the population with serious illness: the “denominator” challenge. J Palliat Med . 2018;21:S7–S16.
    1. Sudore RL, Lum HD, You JJ, Hanson LC, Meier DE, Pantilat SZ, et al. Defining advance care planning for adults: a consensus definition from a multidisciplinary Delphi panel. J Pain Symptom Manage . 2017;53:821–832.e1.
    1. Bailey S. Decision making in health care: limitations of the substituted judgment principle. Nurs Ethics . 2002;9:483–493.
    1. von Gunten CF. Secondary and tertiary palliative care in US hospitals. JAMA . 2002;287:875–881.
    1. Weissman DE, Meier DE. Identifying patients in need of a palliative care assessment in the hospital setting: a consensus report from the Center to Advance Palliative Care. J Palliat Med . 2011;14:17–23.
    1. National Consensus Project for quality palliative care. 4th edition. Richmond, VA: National Coalition for Hospice and Palliative Care; 2018. Clinical Practice Guidelines for quality palliative care.
    1. Dans M, Kutner JS, Agarwal R, Baker JN, Bauman JR, Beck AC, et al. NCCN guidelines insights: palliative care, version 2.2021. J Natl Compr Canc Netw . 2021;19:780–788.
    1. Ferrell BR, Twaddle ML, Melnick A, Meier DE. National Consensus Project clinical practice guidelines for quality palliative care guidelines, 4th edition. J Palliat Med . 2018;21:1684–1689.
    1. Teoli D, Sanvictores T, An J. SWOT analysis. Treasure Island, FL: StatPearls; 2022.
    1. McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques. Int J Clin Pharm . 2016;38:655–662.
    1. Humphrey-Murto S, Crew R, Shea B, Bartlett SJ, March L, Tugwell P, et al. Consensus building in OMERACT: recommendations for use of the Delphi for core outcome set development. J Rheumatol . 2019;46:1041–1046.
    1. Saunders C. The evolution of palliative care. J R Soc Med . 2001;94:430–432.
    1. Brighton LJ, Miller S, Farquhar M, Booth S, Yi D, Gao W, et al. Holistic services for people with advanced disease and chronic breathlessness: a systematic review and meta-analysis. Thorax . 2019;74:270–281.
    1. Haun MW, Estel S, Rucker G, Friederich HC, Villalobos M, Thomas M, et al. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev . 2017;6:CD011129.
    1. Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J, et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA . 2016;316:2104–2114.
    1. Gaertner J, Siemens W, Meerpohl JJ, Antes G, Meffert C, Xander C, et al. Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis. BMJ . 2017;357:j2925.
    1. Sullivan DR, Chan B, Lapidus JA, Ganzini L, Hansen L, Carney PA, et al. Association of early palliative care use with survival and place of death among patients with advanced lung cancer receiving care in the Veterans Health Administration. JAMA Oncol . 2019;5:1702–1709.
    1. Maddocks M, Lovell N, Booth S, Man WD, Higginson IJ. Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease. Lancet . 2017;390:988–1002.
    1. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med . 2010;363:733–742.
    1. Higginson IJ, Bausewein C, Reilly CC, Gao W, Gysels M, Dzingina M, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med . 2014;2:979–987.
    1. Belanger E, Loomer L, Teno JM, Mitchell SL, Adhikari D, Gozalo PL. Early utilization patterns of the new Medicare procedure codes for advance care planning. JAMA Intern Med . 2019;179:829–830.
    1. Harrison KL, Connor SR. First Medicare demonstration of concurrent provision of curative and hospice services for end-of-life care. Am J Public Health . 2016;106:1405–1408.
    1. Limited IM. Washington: D.C.: Association of American Medical Colleges; The complexities of physician supply and demand: projections from 2019 to 2034; p. 2021.
    1. Quill TE, Abernethy AP. Generalist plus specialist palliative care--creating a more sustainable model. N Engl J Med . 2013;368:1173–1175.
    1. Schenker Y, Arnold R. The next era of palliative care. JAMA . 2015;314:1565–1566.
    1. Ray A, Najmi A, Sadasivam B. Integrating palliative care with primary care: a synergistic mix. J Family Med Prim Care . 2019;8:3074–3075.
    1. Raina SK, Kumar R, Gupta RK. A primary care-based patient-centric palliative care model. J Family Med Prim Care . 2019;8:1519–1522.
    1. Bernacki RE, Block SD, American College of Physicians High-Value Care Task Force Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med . 2014;174:1994–2003.
    1. Tulsky JA. Beyond advance directives: importance of communication skills at the end of life. JAMA . 2005;294:359–365.
    1. Weiner JS, Cole SA. Three principles to improve clinician communication for advance care planning: overcoming emotional, cognitive, and skill barriers. J Palliat Med . 2004;7:817–829.
    1. McCorkle R, Jeon S, Ercolano E, Lazenby M, Reid A, Davies M, et al. An advanced practice nurse coordinated multidisciplinary intervention for patients with late-stage cancer: a cluster randomized trial. J Palliat Med . 2015;18:962–969.
    1. Dyar S, Lesperance M, Shannon R, Sloan J, Colon-Otero G. A nurse practitioner-directed intervention improves the quality of life of patients with metastatic cancer: results of a randomized pilot study. J Palliat Med . 2012;15:890–895.
    1. Dosaj A, Thiyagarajan D, Ter Haar C, Cheng J, George J, Wheatley C, et al. Rapid implementation of telehealth services during the COVID-19 pandemic. Telemed J E Health . 2021;27:116–120.
    1. Lurie N, Carr BG. The role of telehealth in the medical response to disasters. JAMA Intern Med . 2018;178:745–746.
    1. Evans R, Stone D, Elwyn G. Organizing palliative care for rural populations: a systematic review of the evidence. Fam Pract . 2003;20:304–310.
    1. Jaffe DH, Lee L, Huynh S, Haskell TP. Health inequalities in the use of telehealth in the United States in the lens of COVID-19. Popul Health Manag . 2020;23:368–377.
    1. Hancock S, Preston N, Jones H, Gadoud A. Telehealth in palliative care is being described but not evaluated: a systematic review. BMC Palliat Care . 2019;18:114.
    1. White C, McIlfatrick S, Dunwoody L, Watson M. Supporting and improving community health services-a prospective evaluation of ECHO technology in community palliative care nursing teams. BMJ Support Palliat Care . 2019;9:202–208.
    1. Arora S, Smith T, Snead J, Zalud-Cerrato S, Marr L, Watson M, et al. Project ECHO: an effective means of increasing palliative care capacity. Am J Manag Care . 2017;23:SP267–SP271.
    1. Schroedl CJ, Yount SE, Szmuilowicz E, Hutchison PJ, Rosenberg SR, Kalhan R. A qualitative study of unmet healthcare needs in chronic obstructive pulmonary disease. A potential role for specialist palliative care? Ann Am Thorac Soc . 2014;11:1433–1438.
    1. Figueiredo D, Gabriel R, Jácome C, Cruz J, Marques A. Caring for relatives with chronic obstructive pulmonary disease: how does the disease severity impact on family carers? Aging Ment Health . 2014;18:385–393.
    1. Carvajalino S, Reigada C, Johnson MJ, Dzingina M, Bajwah S. Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review. BMC Pulm Med . 2018;18:78.
    1. Iyer AS, Dionne-Odom JN, Ford SM, Crump Tims SL, Sockwell ED, Ivankova NV, et al. A formative evaluation of patient and family caregiver perspectives on early palliative care in chronic obstructive pulmonary disease across disease severity. Ann Am Thorac Soc . 2019;16:1024–1033.
    1. Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire C30. J Clin Oncol . 2004;22:3485–3490.
    1. Laugsand EA, Sprangers MA, Bjordal K, Skorpen F, Kaasa S, Klepstad P. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes . 2010;8:104.
    1. Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, et al. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol . 2012;30:1980–1988.
    1. Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med . 2008;177:396–401.
    1. Seow H, Sussman J, Martelli-Reid L, Pond G, Bainbridge D. Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening. J Oncol Pract . 2012;8:e142–e148.
    1. Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol . 2014;32:1480–1501.
    1. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA . 2002;288:3027–3034.
    1. Santana MJ, Feeny D, Johnson JA, McAlister FA, Kim D, Weinkauf J, et al. Assessing the use of health-related quality of life measures in the routine clinical care of lung-transplant patients. Qual Life Res . 2010;19:371–379.
    1. Kroenke K, Krebs EE, Wu J, Yu Z, Chumbler NR, Bair MJ. Telecare collaborative management of chronic pain in primary care: a randomized clinical trial. JAMA . 2014;312:240–248.
    1. Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol . 2016;34:557–565.
    1. Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, et al. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol . 2011;29:994–1000.
    1. Gilbert JE, Howell D, King S, Sawka C, Hughes E, Angus H, et al. Quality improvement in cancer symptom assessment and control: the provincial palliative care integration project (PPCIP) J Pain Symptom Manage . 2012;43:663–678.
    1. Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J . 2019;53:1900164.
    1. Çolak Y, Afzal S. Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry. Eur Respir J . 2010;55:1902226.
    1. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. ESC Committee for Practice Guidelines (CPG) Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J . 2009;30:2493–2537.
    1. Temel JS, Pirl WF, Lynch TJ. Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer. Clin Lung Cancer . 2006;7:241–249.
    1. Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res . 2017;18:67.
    1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 rReport. GOLD executive summary. Am J Respir Crit Care Med . 2017;195:557–582.
    1. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease, and renal disease. J Pain Symptom Manage . 2006;31:58–69.
    1. Mularski RA, Reinke LF, Carrieri-Kohlman V, Fischer MD, Campbell ML, Rocker G, et al. ATS Ad Hoc Committee on Palliative Management of Dyspnea Crisis An official American Thoracic Society workshop report: assessment and palliative management of dyspnea crisis. Ann Am Thorac Soc . 2013;10:S98–S106.
    1. Sullivan DR, Forsberg CW, Ganzini L, Au DH, Gould MK, Provenzale D, et al. Longitudinal changes in depression symptoms and survival among patients with lung cancer: a national cohort assessment. J Clin Oncol . 2016;34:3984–3991.
    1. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax . 1987;42:773–778.
    1. Kon SS, Dilaver D, Mittal M, Nolan CM, Clark AL, Canavan JL, et al. The clinical COPD questionnaire: response to pulmonary rehabilitation and minimal clinically important difference. Thorax . 2014;69:793–798.
    1. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest . 1999;116:1175–1182.
    1. Lovell N, Etkind SN, Bajwah S, Maddocks M, Higginson IJ. To what extent do the NRS and CRQ capture change in patients’ experience of breathlessness in advanced disease? Findings from a mixed-methods double-blind randomized feasibility trial. J Pain Symptom Manage . 2019;58:369–381.e7.
    1. Patel A, Siegert R, Brignall K, Gordon P, Steer S, Desai SR, et al. The development and validation of the King’s brief interstitial lung disease (K-BILD) health status questionnaire. Thorax . 2012;67:804–810.
    1. Sinha A, Patel A, Siegert R, Bajwah S, Maher TM, Renzoni E, et al. The King’s brief interstitial lung disease (KBILD) questionnaire: an updated minimal clinically important difference. BMJ Open Respir Res . 2019;6:e000363.
    1. Mahler DA, Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest . 1995;107:1585–1589.
    1. Limsuwat C, McClellan R, Amiri HM, Nugent K. Pulmonary rehabilitation improves only some domains of health-related quality of life measured by the short form-36 questionnaire. Ann Thorac Med . 2014;9:144–148.
    1. Nolan CM, Longworth L, Lord J, Canavan JL, Jones SE, Kon SS, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax . 2016;71:493–500.
    1. Swigris JJ, Andrae DA, Churney T, Johnson N, Scholand MB, White ES, et al. Development and initial validation analyses of the living with idiopathic pulmonary fibrosis questionnaire. Am J Respir Crit Care Med . 2020;202:1689–1697.
    1. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J . 2009;34:648.
    1. Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax . 2011;66:425.
    1. Nagata K, Tomii K, Hayashi M, Otsuka K, Tachikawa R, Otsuka K. Evaluation of the COPD assessment test (CAT) for measuring health-related quality of life in patients with interstitial lung disease. Eur Respir J . 2011;38:3748.
    1. Hayata A, Minakata Y, Matsunaga K, Nakanishi M, Yamamoto N. Differences in physical activity according to mMRC grade in patients with COPD. Int J Chron Obstruct Pulmon Dis . 2016;11:2203–2208.
    1. Cheng S-L, Lin C-H, Wang C-C, Chan M-C, Hsu J-Y, Hang L-W, et al. Taiwan Clinical Trial Consortium for Respiratory Disease (TCORE) Comparison between COPD assessment test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities, and medical resources utilization in COPD patients. J Formos Med Assoc . 2019;118:429–435.
    1. Yuan X-Y, Zhang H, Huang L-R, Zhang F, Sheng X-W, Cui A. Evaluation of health-related quality of life and the related factors in a group of Chinese patients with interstitial lung diseases. PLoS One . 2020;15:e0236346.
    1. Gift AG. Validation of a vertical visual analogue scale as a measure of clinical dyspnea. Rehabil Nurs . 1989;14:323–325.
    1. Yates H, Adamali HI, Maskell N, Barratt S, Sharp C. Visual analogue scales for interstitial lung disease: a prospective validation study. QJM . 2018;111:531–539.
    1. Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care . 1998;7:200–204.
    1. Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the dyspnoea-12. Thorax . 2010;65:21.
    1. Yorke J, Swigris J, Russell A-M, Moosavi SH, Ng Man Kwong G, Longshaw M, et al. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest . 2011;139:159–164.
    1. Campbell ML, Templin T, Walch J. A respiratory distress observation scale for patients unable to self-report dyspnea. J Palliat Med . 2010;13:285–290.
    1. Campbell ML. Psychometric testing of a respiratory distress observation scale. J Palliat Med . 2008;11:44–50.
    1. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MDL, Pavord ID. Development of a symptom-specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ) Thorax . 2003;58:339–343.
    1. Berkhof FF, Boom LN, ten Hertog NE, Uil SM, Kerstjens HA, van den Berg JW. The validity and precision of the Leicester cough questionnaire in COPD patients with chronic cough. Health Qual Life Outcomes . 2012;10:4.
    1. Hsu JY, Stone RA, Logan-Sinclair RB, Worsdell M, Busst CM, Chung KF. Coughing frequency in patients with persistent cough: assessment using a 24-hour ambulatory recorder. Eur Respir J . 1994;7:1246–1253.
    1. Crawford B, Monz B, Hohlfeld J, Roche N, Rubin B, Magnussen H, et al. Development and validation of a cough and sputum assessment questionnaire. Respir Med . 2008;102:1545–1555.
    1. Monz BU, Sachs P, McDonald J, Crawford B, Nivens MC, Tetzlaff K. Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis. Respir Med . 2010;104:534–541.
    1. O’Brien EC, Hellkamp AS, Neely ML, Swaminathan A, Bender S, Snyder LD, et al. IPF-PRO Registry investigators Disease severity and quality of life in patients with idiopathic pulmonary fibrosis: a cross-sectional analysis of the IPF-PRO registry. Chest . 2020;157:1188–1198.
    1. Johnson AM, Smith SM. A review of general pain measurement tools and instruments for consideration of use in COPD clinical practice. Int J Chron Obstruct Pulmon Dis . 2017;12:923–929.
    1. Shen Q, Guo T, Song M, Guo W, Zhang Y, Duan W, et al. Pain is a common problem in patients with ILD. Respir Res . 2020;21:297.
    1. Chen YW, HajGhanbari B, Road JD, Coxson HO, Camp PG, Reid WD. Reliability and validity of the brief pain inventory in individuals with chronic obstructive pulmonary disease. Eur J Pain . 2018;22:1718–1726.
    1. Maignan M, Chauny J-M, Daoust R, Duc L, Mabiala-Makele P, Collomb-Muret R, et al. Pain during exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. PLoS One . 2019;14:e0217370.
    1. Al-shair K, Muellerova H, Yorke J, Rennard SI, Wouters EF, Hanania NA, et al. ECLIPSE investigators Examining fatigue in COPD: development, validity, and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes . 2012;10:100.
    1. Inal-Ince D, Savci S, Saglam M, Calik E, Arikan H, Bosnak-Guclu M, et al. Fatigue and multidimensional disease severity in chronic obstructive pulmonary disease. Multidiscip Respir Med . 2010;5:162–167.
    1. Talwar A, Sahni S, John S, Verma S, Cárdenas-Garcia J, Kohn N. Effects of pulmonary rehabilitation on fatigue severity scale in patients with lung disease. Pneumonol Alergol Pol . 2014;82:534–540.
    1. Al-shair K, Kolsum U, Berry P, Smith J, Caress A, Singh D, et al. Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale. Thorax . 2009;64:950–955.
    1. Zohal MA, Yazdi Z, Kazemifar AM, Mahjoob P, Ziaeeha M. Sleep quality and quality of life in COPD patients with and without suspected obstructive sleep apnea. Sleep Disord . 2014;2014:508372.
    1. De S. Subjective assessment of quality of sleep in chronic obstructive pulmonary disease patient and its relationship with associated depression. Lung India . 2012;29:332–335.
    1. Vukoja M, Kopitovic I, Milicic D, Dabovic D, Maksimovic O, Ilic M. Sleep quality in patients with asthma and COPD. Eur Respir J . 2015;46:PA4587.
    1. Cho J-G, Teoh A, Roberts M, Wheatley J. The prevalence of poor sleep quality and its associated factors in patients with interstitial lung disease: a cross-sectional analysis. ERJ Open Res . 2019;5:00062–02019.
    1. Faria AC, da Costa CH, Rufino R. Sleep apnea clinical score, Berlin questionnaire, or Epworth sleepiness scale: which is the best obstructive sleep apnea predictor in patients with COPD? Int J Gen Med . 2015;8:275–281.
    1. Lee JH, Park CS, Song JW. Obstructive sleep apnea in patients with interstitial lung disease: prevalence and predictive factors. PLoS One . 2020;15:e0239963.
    1. Puhan MA, Frey M, Büchi S, Schünemann HJ. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes . 2008;6:46.
    1. Holland AE, Fiore JF, Jr, Bell EC, Goh N, Westall G, Symons K, et al. Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology . 2014;19:1215–1221.
    1. von Siemens SM, Jörres RA, Behr J, Alter P, Lutter J, Lucke T, et al. COSYCONET study group Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study. Respir Res . 2019;20:30.
    1. Schuler M, Strohmayer M, Mühlig S, Schwaighofer B, Wittmann M, Faller H, et al. Assessment of depression before and after inpatient rehabilitation in COPD patients: psychometric properties of the German version of the patient health questionnaire (PHQ-9/PHQ-2) J Affect Disord . 2018;232:268–275.
    1. Lu Y, Nyunt MSZ, Gwee X, Feng L, Feng L, Kua EH, et al. Life event stress and chronic obstructive pulmonary disease (COPD): associations with mental well-being and quality of life in a population-based study. BMJ Open . 2012;2:e001674.
    1. Ryerson CJ, Cayou C, Topp F, Hilling L, Camp PG, Wilcox PG, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med . 2014;108:203–210.
    1. Phan T, Carter O, Adams C, Waterer G, Chung LP, Hawkins M, et al. Discriminant validity of the hospital anxiety and depression scale, Beck depression inventory (II) and Beck anxiety inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease. Chron Respir Dis . 2016;13:220–228.
    1. Tzouvelekis A, Karampitsakos T, Kourtidou S, Bouros E, Tzilas V, Katsaras M, et al. Impact of depression on patients with idiopathic pulmonary fibrosis. Front Med (Lausanne) . 2020;7:29.
    1. Collins PF, Elia M, Kurukulaaratchy RJ, Stratton RJ. The influence of deprivation on malnutrition risk in outpatients with chronic obstructive pulmonary disease (COPD) Clin Nutr . 2018;37:144–148.
    1. Emanuel LL, Alpert HR, Emanuel EE. Concise screening questions for clinical assessments of terminal care: the needs near the end-of-life care screening tool. J Palliat Med . 2001;4:465–474.
    1. Scandrett KG, Reitschuler-Cross EB, Nelson L, Sanger JA, Feigon M, Boyd E, et al. Feasibility and effectiveness of the NEST13+ as a screening tool for advanced illness care needs. J Palliat Med . 2010;13:161–169.
    1. Cox CE, Jones DM, Reagan W, Key MD, Chow V, McFarlin J, et al. Palliative care planner: a pilot study to evaluate acceptability and usability of an electronic health records system-integrated, needs-targeted app platform. Ann Am Thorac Soc . 2018;15:59–68.
    1. Cox CE, Ashana DC, Haines KL, Casarett D, Olsen MK, Parish A, et al. Assessment of clinical palliative care trigger status vs actual needs among critically ill patients and their family members. JAMA Netw Open . 2022;5:e2144093.
    1. Bausewein C, Booth S, Gysels M, Kühnbach R, Haberland B, Higginson IJ. Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med . 2010;13:1109–1118.
    1. Malik FA, Gysels M, Higginson IJ. Living with breathlessness: a survey of caregivers of breathless patients with lung cancer or heart failure. Palliat Med . 2013;27:647–656.
    1. Meharry R, Anderson D. Assessing symptom burden in patients with advanced COPD – Is CAT enough? Eur Respir J . 2016;48:PA3731.
    1. Rantala HA, Leivo-Korpela S, Lehtimaki L, Lehto JT. Assessing symptom burden and depression in subjects with chronic respiratory insufficiency. J Palliat Care . 2021;37:134–141.
    1. McGee SF, Zhang T, Jonker H, Laurie SA, Goss G, Nicholas G, et al. The impact of baseline Edmonton symptom assessment scale scores on treatment and survival in patients with advanced non-small-cell lung cancer. Clin Lung Cancer . 2018;19:e91–e99.
    1. Kim HJ, McGuire DB, Tulman L, Barsevick AM. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs . 2005;28:270–282, quiz 283–284.
    1. Miaskowski C. Symptom clusters: establishing the link between clinical practice and symptom management research. Support Care Cancer . 2006;14:792–794.
    1. Jenkins BA, Athilingam P, Jenkins RA. Symptom clusters in chronic obstructive pulmonary disease: a systematic review. Appl Nurs Res . 2019;45:23–29.
    1. Seppälä S, Rajala K, Lehto JT, Sutinen E, Mäkitalo L, Kautiainen H, et al. Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis. ERJ Open Res . 2020;6:00347–2020.
    1. Kirkova J, Aktas A, Walsh D, Davis MP. Cancer symptom clusters: clinical and research methodology. J Palliat Med . 2011;14:1149–1166.
    1. Seamark DA, Blake SD, Seamark CJ, Halpin DM. Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. An interpretative phenomenological analysis. Palliat Med . 2004;18:619–625.
    1. Farquhar MC, Prevost AT, McCrone P, Brafman-Price B, Bentley A, Higginson IJ, et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med . 2014;12:194.
    1. Sloan DH, BrintzenhofeSzoc K, Mistretta E, Cheng MJ, Berger A. The influence of relationships on the meaning-making process: patients’ perspectives. Ann Palliat Med . 2017;6:220–226.
    1. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev . 2015;(2):CD003793.
    1. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev . 2014;(10):CD006322.
    1. Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, et al. Canadian Thoracic Society COPD Committee Dyspnea Expert Working Group Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J . 2011;18:69–78.
    1. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. American Thoracic Society Committee on Dyspnea An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med . 2012;185:435–452.
    1. Bailey CD, Wagland R, Dabbour R, Caress A, Smith J, Molassiotis A. An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses. BMC Pulm Med . 2010;10:63.
    1. Hui D, Maddocks M, Johnson MJ, Ekström M, Simon ST, Ogliari AC, et al. ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org Management of breathlessness in patients with cancer: ESMO clinical practice guidelines†. ESMO Open . 2020;5:e001038.
    1. Khor YH, Dudley KA, Herman D, Jacobs SS, Lederer DJ, Krishnan JA, et al. Summary for clinicians: clinical practice guideline on home oxygen therapy for adults with chronic lung disease. Ann Am Thorac Soc . 2021;18:1444–1449.
    1. Booth S, Farquhar M, Gysels M, Bausewein C, Higginson IJ. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study. Palliat Support Care . 2006;4:287–293.
    1. Molassiotis A, Bryan G, Caress A, Bailey C, Smith J. Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: a systematic review of the literature. Respir Med . 2010;104:934–944.
    1. Gibson PG, Vertigan AE. Speech pathology for chronic cough: a new approach. Pulm Pharmacol Ther . 2009;22:159–162.
    1. Chamberlain S, Birring SS, Garrod R. Nonpharmacological interventions for refractory chronic cough patients: systematic review. Lung . 2014;192:75–85.
    1. Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Domingo Ribas C, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J . 2020;55:1901136.
    1. Wee B, Browning J, Adams A, Benson D, Howard P, Klepping G, et al. Management of chronic cough in patients receiving palliative care: review of evidence and recommendations by a task group of the Association for Palliative Medicine of Great Britain and Ireland. Palliat Med . 2012;26:780–787.
    1. Molassiotis A, Bailey C, Caress A, Tan JY. Interventions for cough in cancer. Cochrane Database Syst Rev . 2015;5:CD007881.
    1. Gibson P, Wang G, McGarvey L, Vertigan AE, Altman KW, Birring SS, CHEST Expert Cough Panel Treatment of unexplained chronic cough: CHEST guideline and expert panel report. Chest . 2016;149:27–44.
    1. Chen YW, Wang HH. The effectiveness of acupressure on relieving pain: a systematic review. Pain Manag Nurs . 2014;15:539–550.
    1. Nahin RL, Boineau R, Khalsa PS, Stussman BJ, Weber WJ. Evidence-based evaluation of complementary health approaches for pain management in the United States. Mayo Clin Proc . 2016;91:1292–1306.
    1. Tick H, Nielsen A, Pelletier KR, Bonakdar R, Simmons S, Glick R, et al. Pain Task Force of the Academic Consortium for Integrative Medicine and Health Evidence-based nonpharmacologic strategies for comprehensive pain care: the consortium pain task force white paper. Explore (NY) . 2018;14:177–211.
    1. Bradt J, Dileo C, Magill L, Teague A. Music interventions for improving psychological and physical outcomes in cancer patients. Cochrane Database Syst Rev . 2016:CD006911.
    1. Chou R, Wagner J, Ahmed AY, Blazina I, Brodt E, Buckley DI, et al. Treatments for acute pain: a systematic review. Comparative effectiveness review no. 240. Rockville, MD: Agency for Healthcare Research and Quality; 2020.
    1. Fine PG. Treatment guidelines for the pharmacological management of pain in older persons. Pain Med . 2012;13:S57–S66.
    1. Chapman EJ, Edwards Z, Boland JW, Maddocks M, Fettes L, Malia C, et al. Practice review: evidence-based and effective management of pain in patients with advanced cancer. Palliat Med . 2020;34:444–453.
    1. Perusinghe M, Chen KY, McDermott B. Evidence-based management of depression in palliative care: a systematic review. J Palliat Med . 2021;24:767–781.
    1. Rayner L, Price A, Hotopf M, Higginson IJ. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer . 2011;47:702–712.
    1. Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, Hameleers N, Wouters EFM, Janssen DJA. Effect of sustained-release morphine for refractory breathlessness in chronic obstructive pulmonary disease on health status: a randomized clinical trial. JAMA Intern Med . 2020;180:1306–1314.
    1. Zwerink M, Brusse-Keizer M, van der Valk PD, Zielhuis GA, Monninkhof EM, van der Palen J, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev . 2014;(3):CD002990.
    1. Riegel B, Jaarsma T, Strömberg A. A middle-range theory of self-care of chronic illness. ANS Adv Nurs Sci . 2012;35:194–204.
    1. Braido F, Baiardini I, Menoni S, Bagnasco AM, Balbi F, Bocchibianchi S, et al. Disability in COPD and its relationship to clinical and patient-reported outcomes. Curr Med Res Opin . 2011;27:981–986.
    1. Clari M, Matarese M, Ivziku D, De Marinis MG. Self-care of people with chronic obstructive pulmonary disease: a meta-synthesis. Patient . 2017;10:407–427.
    1. Jalota L, Jain VV. Action plans for COPD: strategies to manage exacerbations and improve outcomes. Int J Chron Obstruct Pulmon Dis . 2016;11:1179–1188.
    1. Russell AM, Adamali H, Molyneaux PL, Lukey PT, Marshall RP, Renzoni EA, et al. Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med . 2016;194:989–997.
    1. Holm S.Principles of biomedical ethics, 5th ed J Med Ethics 200228332.
    1. Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A. The effects of advance care planning on end-of-life care: a systematic review. Palliat Med . 2014;28:1000–1025.
    1. Vranas KC, Plinke W, Bourne D, Kansagara D, Lee RY, Kross EK, et al. The influence of POLST on treatment intensity at the end of life: a systematic review. J Am Geriatr Soc . 2021;69:3661–3674.
    1. Simpson C. Advance care planning in COPD: care versus “code status”. Chron Respir Dis . 2012;9:193–204.
    1. Heyland DK, Dodek P, Rocker G, Groll D, Gafni A, Pichora D, et al. Canadian Researchers End-of-Life Network(CARENET) What matters most in end-of-life care: perceptions of seriously ill patients and their family members. CMAJ . 2006;174:627–633.
    1. Goodridge D, Duggleby W, Gjevre J, Rennie D. Caring for critically ill patients with advanced COPD at the end of life: a qualitative study. Intensive Crit Care Nurs . 2008;24:162–170.
    1. Sudore RL, Fried TR. Redefining the “planning” in advance care planning: preparing for end-of-life decision making. Ann Intern Med . 2010;153:256–261.
    1. Hsieh HF, Shannon SE, Curtis JR. Contradictions and communication strategies during end-of-life decision-making in the intensive care unit. J Crit Care . 2006;21:294–304.
    1. Nevins ML, Epstein SK. Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest . 2001;119:1840–1849.
    1. Khalaila R, Zbidat W, Anwar K, Bayya A, Linton DM, Sviri S. Communication difficulties and psychoemotional distress in patients receiving mechanical ventilation. Am J Crit Care . 2011;20:470–479.
    1. Claessens MT, Lynn J, Zhong Z, Desbiens NA, Phillips RS, Wu AW, et al. Study to understand prognoses and preferences for outcomes and risks of treatments Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. J Am Geriatr Soc . 2000;48:S146–S153.
    1. Kirchhoff KT, Hammes BJ, Kehl KA, Briggs LA, Brown RL. Effect of a disease-specific planning intervention on surrogate understanding of patient goals for future medical treatment. J Am Geriatr Soc . 2010;58:1233–1240.
    1. Perkins HS. Controlling death: the false promise of advance directives. Ann Intern Med . 2007;147:51–57.
    1. Fagerlin A, Schneider CE. Enough. The failure of the living will. Hastings Cent Rep . 2004;34:30–42.
    1. Hickman SE, Hammes BJ, Moss AH, Tolle SW. Hope for the future: achieving the original intent of advance directives. Hastings Cent Rep . 2005;Spec No:S26–S30.
    1. Dying in America: improving quality and honoring individual preferences near the end of life. Mil Med . 2015;180:365–367.
    1. Gardiner C, Gott M, Small N, Payne S, Seamark D, Barnes S, et al. Living with advanced chronic obstructive pulmonary disease: patients concerns regarding death and dying. Palliat Med . 2009;23:691–697.
    1. Heffner JE. Advance care planning in chronic obstructive pulmonary disease: barriers and opportunities. Curr Opin Pulm Med . 2011;17:103–109.
    1. Fleuren N, Depla MFIA, Janssen DJA, Huisman M, Hertogh CMPM. Underlying goals of advance care planning (ACP): a qualitative analysis of the literature. BMC Palliat Care . 2020;19:27.
    1. MacKenzie MA, Smith-Howell E, Bomba PA, Meghani SH. Respecting choices and related models of advance care planning: a systematic review of published evidence. Am J Hosp Palliat Care . 2018;35:897–907.
    1. Sean Morrison R. Advance directives/care planning: clear, simple, and wrong. J Palliat Med . 2020;23:878–879.
    1. Halpern SD. Goal-concordant care - searching for the holy grail. N Engl J Med . 2019;381:1603–1606.
    1. Meehan E, Foley T, Kelly C, Burgess Kelleher A, Sweeney C, Hally RM, et al. Advance care planning for individuals with chronic obstructive pulmonary disease: a scoping review of the literature. J Pain Symptom Manage . 2020;59:1344–1361.
    1. Gott M, Gardiner C, Small N, Payne S, Seamark D, Barnes S, et al. Barriers to advance care planning in chronic obstructive pulmonary disease. Palliat Med . 2009;23:642–648.
    1. Fulmer T, Escobedo M, Berman A, Koren MJ, Hernández S, Hult A. Physicians’ views on advance care planning and end-of-life care conversations. J Am Geriatr Soc . 2018;66:1201–1205.
    1. Jabbarian LJ, Zwakman M, van der Heide A, Kars MC, Janssen DJA, van Delden JJ, et al. Advance care planning for patients with chronic respiratory diseases: a systematic review of preferences and practices. Thorax . 2018;73:222–230.
    1. Chan CWH, Ng NHY, Chan HYL, Wong MMH, Chow KM. A systematic review of the effects of advance care planning facilitators training programs. BMC Health Serv Res . 2019;19:362.
    1. Fessler HE, Addrizzo-Harris D, Beck JM, Buckley JD, Pastores SM, Piquette CA, et al. Entrustable professional activities and curricular milestones for fellowship training in pulmonary and critical care medicine: report of a multisociety working group. Chest . 2014;146:813–834.
    1. Morrison RS, Meier DE, Arnold RM. What’s wrong with advance care planning? JAMA . 2021;326:1575–1576.
    1. Farquhar M, Bausewein C, Currow DC, Johnson MJ.Supporting informal carersPalliative care in respiratory disease: ERS monograph. Lausanne, Switzerland: European Respiratory Society; 2016258.
    1. Anderson EW, White KM. “It Has Changed My Life”: an exploration of caregiver experiences in serious illness. Am J Hosp Palliat Care . 2018;35:266–274.
    1. Farquhar M. Assessing carer needs in chronic obstructive pulmonary disease. Chron Respir Dis . 2018;15:26–35.
    1. Klein S, Logan A, Lindell KO. A scoping review of unmet needs of caregivers of patients with pulmonary fibrosis. Curr Opin Support Palliat Care . 2021;15:226–232.
    1. Graney BA, Wamboldt FS, Baird S, Churney T, Fier K, Korn M, et al. Informal caregivers experience of supplemental oxygen in pulmonary fibrosis. Health Qual Life Outcomes . 2017;15:133.
    1. Lindell KO, Collins EG, Catanzarite L, Garvey CM, Hernandez C, Mclaughlin S, et al. Equipment, access and worry about running short of oxygen: key concerns in the ATS patient supplemental oxygen survey. Heart Lung . 2019;48:245–249.
    1. Micklewright K, Farquhar M. Does the carer support needs assessment tool cover the established support needs of carers of patients with chronic obstructive pulmonary disease? A systematic literature search and narrative review. Palliat Med . 2020;34:1305–1315.
    1. Micklewright K, Farquhar M. Face and content validity of the carer support needs assessment tool (CSNAT), and feasibility of the CSNAT intervention for carers of patients with chronic obstructive pulmonary disease. Chronic Illn . 2021 doi: 10.1177/1742395321999433.
    1. Caring Bridge. 2021.
    1. Davidson PM, Phillips JL, Dennison-Himmelfarb C, Thompson SC, Luckett T, Currow DC. Providing palliative care for cardiovascular disease from a perspective of sociocultural diversity: a global view. Curr Opin Support Palliat Care . 2016;10:11–17.
    1. Hawley P. Barriers to access to palliative care. Palliat Care . 2017;10:1178224216688887.
    1. Aldridge MD, Hasselaar J, Garralda E, van der Eerden M, Stevenson D, McKendrick K, et al. Education, implementation, and policy barriers to greater integration of palliative care: a literature review. Palliat Med . 2016;30:224–239.
    1. Johnson KS. Racial and ethnic disparities in palliative care. J Palliat Med . 2013;16:1329–1334.
    1. Hoerger M, Perry LM, Korotkin BD, Walsh LE, Kazan AS, Rogers JL, et al. Statewide differences in personality associated with geographic disparities in access to palliative care: findings on openness. J Palliat Med . 2019;22:628–634.
    1. Friedman J, Kim D, Schneberk T, Bourgois P, Shin M, Celious A, et al. Assessment of racial/ethnic and income disparities in the prescription of opioids and other controlled medications in California. JAMA Intern Med . 2019;179:469–476.
    1. Enzinger AC, Ghosh K, Keating NL, Cutler DM, Landrum MB, Wright AA. US trends and racial/ethnic disparities in opioid access among patients with poor prognosis cancer at the end of life (EOL) J Clin Oncol . 2020;38:7005.
    1. Seya MJ, Gelders SF, Achara OU, Milani B, Scholten WK. A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels. J Pain Palliat Care Pharmacother . 2011;25:6–18.
    1. De Lima L, Sweeney C, Palmer JL, Bruera E. Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother . 2004;18:59–70.
    1. De Lima L. Opioid availability in Latin America as a global problem: a new strategy with regional and national effects. J Palliat Med . 2004;7:97–103.
    1. Cherny NI, Cleary J, Scholten W, Radbruch L, Torode J. The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America, and the Caribbean, and the Middle East: introduction and methodology. Ann Oncol . 2013;24:xi7–xi13.
    1. Cintron A, Morrison RS. Pain and ethnicity in the United States: a systematic review. J Palliat Med . 2006;9:1454–1473.
    1. Morrison RS, Wallenstein S, Natale DK, Senzel RS, Huang LL. “We don’t carry that”--failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med . 2000;342:1023–1026.
    1. Adegunsoye A, Vela M, Saunders M. Racial disparities in pulmonary fibrosis and the impact on the Black population. Arch Bronconeumol . 2021 doi: 10.1016/j.arbres.2021.09.012.
    1. Schraufnagel DE, Blasi F, Kraft M, Gaga M, Finn PW, Rabe KF, ATS/ERS Committee on Disparities in Respiratory Health An official American Thoracic Society/European Respiratory Society policy statement: disparities in respiratory health. Am J Respir Crit Care Med . 2013;188:865–871.
    1. Welch LC, Teno JM, Mor V. End-of-life care in Black and White: race matters for medical care of dying patients and their families. J Am Geriatr Soc . 2005;53:1145–1153.
    1. Gordon HS, Street RL, Sharf BF, Souchek J. Racial differences in doctors’ information-giving and patients’ participation. Cancer . 2006;107:1313–1320.
    1. Gordon HS, Street RL, Jr, Sharf BF, Kelly PA, Souchek J. Racial differences in trust and lung cancer patients’ perceptions of physician communication. J Clin Oncol . 2006;24:904–909.
    1. Yaqoob ZJ, Al-Kindi SG, Zein JG. Trends and disparities in hospice use among patients dying of COPD in the United States. Chest . 2017;151:1183–1184.
    1. Brown CE, Engelberg RA, Sharma R, Downey L, Fausto JA, Sibley J, et al. Race/ethnicity, socioeconomic status, and healthcare intensity at the end of life. J Palliat Med . 2018;21:1308–1316.
    1. Kwak J, Salmon JR. Attitudes and preferences of Korean-American older adults and caregivers on end-of-life care. J Am Geriatr Soc . 2007;55:1867–1872.
    1. Kelley AS, Wenger NS, Sarkisian CA. Opiniones: end-of-life care preferences and planning of older Latinos. J Am Geriatr Soc . 2010;58:1109–1116.
    1. Sanders JJ, Robinson MT, Block SD. Factors impacting advance care planning among African Americans: results of a systematic, integrated review. J Palliat Med . 2016;19:202–227.
    1. Bazargan M, Bazargan-Hejazi S. Disparities in palliative and hospice care and completion of advance care planning and directives among non-Hispanic Blacks: a scoping review of recent literature. Am J Hosp Palliat Care . 2021;38:688–718.
    1. Portanova J, Ailshire J, Perez C, Rahman A, Enguidanos S. Ethnic differences in advance directive completion and care preferences: what has changed in a decade? J Am Geriatr Soc . 2017;65:1352–1357.
    1. LoPresti MA, Dement F, Gold HT. End-of-life care for people with cancer from ethnic minority groups: a systematic review. Am J Hosp Palliat Care . 2016;33:291–305.
    1. Evans MK, Rosenbaum L, Malina D, Morrissey S, Rubin EJ. Diagnosing and treating systemic racism. N Engl J Med . 2020;383:274–276.
    1. Ferrell B, Connor SR, Cordes A, Dahlin CM, Fine PG, Hutton N, et al. National Consensus Project for Quality Palliative Care Task Force Members The national agenda for quality palliative care: the National Consensus Project and the national quality forum. J Pain Symptom Manage . 2007;33:737–744.
    1. Enguidanos S, Kogan AC, Lorenz K, Taylor G. Use of role model stories to overcome barriers to hospice among African Americans. J Palliat Med . 2011;14:161–168.
    1. Volandes AE, Ariza M, Abbo ED, Paasche-Orlow M. Overcoming educational barriers for advance care planning in Latinos with video images. J Palliat Med . 2008;11:700–706.
    1. Volandes AE, Paasche-Orlow M, Gillick MR, Cook EF, Shaykevich S, Abbo ED, et al. Health literacy not race predicts end-of-life care preferences. J Palliat Med . 2008;11:754–762.
    1. Fischer SM, Sauaia A, Kutner JS. Patient navigation: a culturally competent strategy to address disparities in palliative care. J Palliat Med . 2007;10:1023–1028.
    1. Morrison RS, Zayas LH, Mulvihill M, Baskin SA, Meier DE. Barriers to completion of healthcare proxy forms: a qualitative analysis of ethnic differences. J Clin Ethics . 1998;9:118–126.
    1. Liu JM, Lin WC, Chen YM, Wu HW, Yao NS, Chen LT, et al. The status of the do-not-resuscitate order in Chinese clinical trial patients in a cancer centre. J Med Ethics . 1999;25:309–314.
    1. Garrido MM, Harrington ST, Prigerson HG. End-of-life treatment preferences: a key to reducing ethnic/racial disparities in advance care planning? Cancer . 2014;120:3981–3986.
    1. Cain CL, Surbone A, Elk R, Kagawa-Singer M. Culture and palliative care: preferences, communication, meaning, and mutual decision making. J Pain Symptom Manage . 2018;55:1408–1419.
    1. Wanko Keutchafo EL, Kerr J, Jarvis MA. Evidence of nonverbal communication between nurses and older adults: a scoping review. BMC Nurs . 2020;19:53.
    1. Stepanikova I, Zhang Q, Wieland D, Eleazer GP, Stewart T. Non-verbal communication between primary care physicians and older patients: how does race matter? J Gen Intern Med . 2012;27:576–581.
    1. Elliott AM, Alexander SC, Mescher CA, Mohan D, Barnato AE. Differences in physicians’ verbal and nonverbal communication with Black and White patients at the end of life. J Pain Symptom Manage . 2016;51:1–8.
    1. Pham K, Thornton JD, Engelberg RA, Jackson JC, Curtis JR. Alterations during medical interpretation of ICU family conferences that interfere with or enhance communication. Chest . 2008;134:109–116.
    1. Thornton JD, Pham K, Engelberg RA, Jackson JC, Curtis JR. Families with limited English proficiency receive less information and support in interpreted intensive care unit family conferences. Crit Care Med . 2009;37:89–95.
    1. Smith AK, Sudore RL, Perez-Stable EJ. Palliative care for Latino patients and their families: whenever we prayed, she wept. JAMA . 2009;301:1047–1057, E1.
    1. Kagawa-Singer M, Blackhall LJ. Negotiating cross-cultural issues at the end of life: “You got to go where he lives”. JAMA . 2001;286:2993–3001.
    1. Hern HE, Jr, Koenig BA, Moore LJ, Marshall PA. The difference that culture can make in end-of-life decision-making. Camb Q Healthc Ethics . 1998;7:27–40.
    1. Carrese JA, Rhodes LA. Western bioethics on the Navajo reservation. Benefit or harm? JAMA . 1995;274:826–829.
    1. Anderson RJ, Stone PC, Low JTS, Bloch S. Managing uncertainty and references to time in prognostic conversations with family members at the end of life: a conversation analytic study. Palliat Med . 2020;34:896–905.
    1. Krawczyk M, Gallagher R. Communicating prognostic uncertainty in potential end-of-life contexts: experiences of family members. BMC Palliat Care . 2016;15:59.
    1. 2009 UNISDR terminology and disaster risk reduction. Geneva, Switzerland: United Nations Office for Disaster Risk Reduction; 2009.
    1. Wilkinson A. The potential role for palliative care in mass casualty events. J Palliat Care Med . 2012;2:1000e112.
    1. Kelly M, Mitchell I, Walker I, Mears J, Scholz B. End-of-life care in natural disasters including epidemics and pandemics: a systematic review. BMJ Support Palliat Care . 2021 doi: 10.1136/bmjspcare-2021-002973.
    1. Arya A, Buchman S, Gagnon B, Downar J. Pandemic palliative care: beyond ventilators and saving lives. CMAJ . 2020;192:E400–E404.
    1. Matzo M, Wilkinson A, Lynn J, Gatto M, Phillips S. Palliative care considerations in mass casualty events with scarce resources. Biosecur Bioterror . 2009;7:199–210.
    1. Phillips S, Knebel A, Mass medical care with scarce resources: a community planning guide 2007.
    1. Zalenski RJ, Jones SS, Courage C, Waselewsky DR, Kostaroff AS, Kaufman D, et al. Impact of palliative care screening and consultation in the ICU: a multihospital quality improvement project. J Pain Symptom Manage . 2017;53:5–12.e3.
    1. Quinn KL, Shurrab M, Gitau K, Kavalieratos D, Isenberg SR, Stall NM, et al. Association of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness: a systematic review and meta-analysis. JAMA . 2020;324:1439–1450.
    1. de Wolf-Linder S, Dawkins M, Wicks F, Pask S, Eagar K, Evans CJ, et al. Which outcome domains are important in palliative care and when? An international expert consensus workshop using the nominal group technique. Palliat Med . 2019;33:1058–1068.
    1. Aslakson RA, Reinke LF, Cox C, Kross EK, Benzo RP, Curtis JR. Developing a research agenda for integrating palliative care into critical care and pulmonary practice to improve patient and family outcomes. J Palliat Med . 2017;20:329–343.
    1. Collins LM, Murphy SA, Strecher V. The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions. Am J Prev Med . 2007;32(5, Suppl):S112–S118.
    1. Kamal AH, Wolf SP, Troy J, Leff V, Dahlin C, Rotella JD, et al. Policy changes key to promoting sustainability and growth of the specialty palliative care workforce. Health Aff (Millwood) . 2019;38:910–918.
    1. Kamal AH, Docherty SL, Reeve BB, Samsa GP, Bosworth HB, Pollak KI. Helping the demand find the supply: messaging the value of specialty palliative care directly to those with serious illnesses. J Pain Symptom Manage . 2019;57:e6–e7.
    1. Wysham NG, Hua M, Hough CL, Gundel S, Docherty SL, Jones DM, et al. Improving ICU-based palliative care delivery: a multicenter, multidisciplinary survey of critical care clinician attitudes and beliefs. Crit Care Med . 2017;45:e372–e378.
    1. Aslakson RA, Ast K, AAHPM Research Committee Writing Group Introduction to a new special series for the journal of pain and symptom management-science in action: evidence and opportunities for palliative care across diverse populations and care settings. J Pain Symptom Manage . 2019;58:134–136.
    1. King JD, Eickhoff J, Traynor A, Campbell TC. Integrated onco-palliative care associated with prolonged survival compared to standard care for patients with advanced lung cancer: a retrospective review. J Pain Symptom Manage . 2016;51:1027–1032.
    1. Bajwah S, Oluyase AO, Yi D, Gao W, Evans CJ, Grande G, et al. The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers. Cochrane Database Syst Rev . 2020;9:CD012780.
    1. Eisenstadt M, Liverpool S, Infanti E, Ciuvat RM, Carlsson C. Mobile apps that promote emotion regulation, positive mental health, and well-being in the general population: systematic review and meta-analysis. JMIR Ment Health . 2021;8:e31170.
    1. Pinto S, Caldeira S, Martins JC. e-Health in palliative care: review of literature, Google Play and App Store. Int J Palliat Nurs . 2017;23:394–401.
    1. Putranto D, Rochmawati E. Mobile applications for managing symptoms of patients with cancer at home: a scoping review. Int J Nurs Pract . 2020;26:e12842.
    1. Turnbull AE, Hartog CS. Goal-concordant care in the ICU: a conceptual framework for future research. Intensive Care Med . 2017;43:1847–1849.
    1. Sanders JJ, Miller K, Desai M, Geerse OP, Paladino J, Kavanagh J, et al. Measuring goal-concordant care: results and reflections from secondary analysis of a trial to improve serious illness communication. J Pain Symptom Manage . 2020;60:889–897.e2.
    1. Campbell ML, Donesky D, Sarkozy A, Reinke LF. Treatment of dyspnea in advanced disease and at the end of life. J Hosp Palliat Nurs . 2021;23:406–420.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться